Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Crohn's disease, a chronic inflammation of the gastro-intestinal tract, is a disease with a complex pathogenetic background. Hereditary factors, environmental factors and the gut flora play a varying role in its onset, however, this role remains unclear to date. We hypothesize to detect tiny fragments of microbial DNA from the gut in the bloodstream, due to disruption in the natural defences of the gut lining. If this is true, it may hold the key to understanding why Crohn's disease recurs after surgery.
Our objective in this study is to test retrospectively, if we can detect any difference in microbial DNA from the blood of ileocolonic resection (ICR) patients that do and do not show recurrence at the time of follow-up endoscopy at 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Non-recurrence patients | Patients that do not have postoperative recurrence at colonoscopy 6 months after surgery. | ||
| Recurrence patients | Patients that do have postoperative recurrence at colonoscopy 6 months after surgery. | ||
| Healthy controls | Patients without Inflammatory Bowel Disease |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Differences in bloodmicrobiome between recurrence & non recurrence patients. | To test retrospectively, if we can detect any difference in microbial DNA from the blood of ICR patients that do and do not show recurrence, defined as a Rutgeerts score ≥ i2b at the time of follow-up endoscopy at 6 months. | From enrollment to the postoperative endoscopy (at 6 months follow-up). |
| Measure | Description | Time Frame |
|---|---|---|
| o To identify blood biomarkers predicting postoperative recurrence in Crohn's disease. | From enrollment to the postoperative endoscopy (at 6 months follow-up). | |
| o To identify histological parameters predicting postoperative recurrence in Crohn's disease. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients will be identified at the outpatient clinic at the dept. of gastroenterology or department of surgery or at a multidisciplinary meeting.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Merel Verweij, MD | Contact | +31650033976 | m.verweij@erasmusmc.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Erasmus Medical Center | Rotterdam | South Holland | 3015 GD | Netherlands |
Not provided
Not provided
Not provided
Not provided
Blood, feces, biopsies and resection material
| From enrollment to the postoperative endoscopy (at 6 months follow-up). |
| o To correlate blood biomarkers with fecal biomarkers predicting postoperative recurrence in Crohn's disease. | From enrollment to the postoperative endoscopy (at 6 months follow-up). |